Carisoprodol - referral | European Medicines Agency (EMA)
www.ema.europa.eu
The European Medicines Agency (EMEA) has completed a review of the safety of carisoprodol. The Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that the benefits of medicines containing carisoprodol no longer outweigh their risks, and that all marketing authorisations for these products should be suspended throughout Europe.
This is an automated archive made by the Lemmit Bot.

The original was posted on /r/todayilearned by /u/RecetaDeAlprazolam on 2025-06-24 20:43:58+00:00.

Original Title: TIL the muscle relaxant Carisoprodol (Soma) was taken off the markets in Europe in 2008 for risk of causing intoxication (affecting mental state) and psychomotor impairment (unusual thoughts and difficulty co-ordinating movements).